SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-19-063331
Filing Date
2019-11-13
Accepted
2019-11-13 16:18:11
Documents
43
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q tm1919485-1_10q.htm 10-Q 467164
2 EXHIBIT 31.1 tm19194851_ex31-1.htm EX-31.1 9524
3 EXHIBIT 31.2 tm19194851_ex31-2.htm EX-31.2 9314
4 EXHIBIT 32.1 tm19194851_ex32-1.htm EX-32.1 4017
5 EXHIBIT 32.2 tm19194851_ex32-2.htm EX-32.2 3671
  Complete submission text file 0001104659-19-063331.txt   2164700

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT atxi-20190930.xml EX-101.INS 385246
7 XBRL TAXONOMY EXTENSION SCHEMA atxi-20190930.xsd EX-101.SCH 20218
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE atxi-20190930_cal.xml EX-101.CAL 19692
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE atxi-20190930_def.xml EX-101.DEF 84465
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE atxi-20190930_lab.xml EX-101.LAB 177207
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE atxi-20190930_pre.xml EX-101.PRE 158975
Mailing Address 2 GANSEVOORT STREET 9TH FLOOR NEW YORK NY 10014
Business Address 2 GANSEVOORT STREET 9TH FLOOR NEW YORK NY 10014 781-652-4500
AVENUE THERAPEUTICS, INC. (Filer) CIK: 0001644963 (see all company filings)

IRS No.: 474113275 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38114 | Film No.: 191214208
SIC: 2834 Pharmaceutical Preparations